loader
Please Wait
Applying Filters...

Euroapi Company Header Euroapi Company Header

X

Technical details about LUT-014, learn more about the structure, uses, toxicity, action, side effects and more

Client Email Product
Menu
2D Structure
1. Also known as: Lut014, 2274819-46-2, Lut-014, T4e4i523ry, Lut-014 [who-dd], 6-methyl-5-n-[3-(7h-purin-6-yl)pyridin-2-yl]-1-n-[3-(trifluoromethoxy)phenyl]isoquinoline-1,5-diamine
Molecular Formula
C27H19F3N8O
Molecular Weight
528.5  g/mol
InChI Key
FZPYULHBUBXPIG-UHFFFAOYSA-N
FDA UNII
T4E4I523RY

BRAF Inhibitor LUT014 is a topically bioavailable small molecule inhibitor of serine/threonine-protein kinase B-raf (BRAF) protein with potential chemoprotective activity. Upon topical administration, BRAF inhibitor LUT014 targets and binds BRAF and, through the paradoxical effect of BRAF inhibition, induces mitogen-activated protein kinase (MAPK) signaling, which leads to the proliferation and migration of healthy human keratinocytes. This decreases dermal toxicities associated with epidermal growth factor (EGFR) inhibitor therapy. BRAF, a member of the raf family of serine/threonine protein kinases, plays a role in the regulation of MAPK/extracellular signal-regulated kinase (ERK) signaling pathways.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
6-methyl-5-N-[3-(7H-purin-6-yl)pyridin-2-yl]-1-N-[3-(trifluoromethoxy)phenyl]isoquinoline-1,5-diamine
2.1.2 InChI
InChI=1S/C27H19F3N8O/c1-15-7-8-19-18(9-11-32-24(19)37-16-4-2-5-17(12-16)39-27(28,29)30)21(15)38-25-20(6-3-10-31-25)22-23-26(35-13-33-22)36-14-34-23/h2-14H,1H3,(H,31,38)(H,32,37)(H,33,34,35,36)
2.1.3 InChI Key
FZPYULHBUBXPIG-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=C(C2=C(C=C1)C(=NC=C2)NC3=CC(=CC=C3)OC(F)(F)F)NC4=C(C=CC=N4)C5=C6C(=NC=N5)N=CN6
2.2 Other Identifiers
2.2.1 UNII
T4E4I523RY
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 6-methyl-5-n-(3-(7h-purin-6-yl)pyridin-2-yl)-1-n-(3-(trifluoromethoxy)phenyl)isoquinoline-1,5-diamine

2. Lut014

2.3.2 Depositor-Supplied Synonyms

1. Lut014

2. 2274819-46-2

3. Lut-014

4. T4e4i523ry

5. Lut-014 [who-dd]

6. 6-methyl-5-n-[3-(7h-purin-6-yl)pyridin-2-yl]-1-n-[3-(trifluoromethoxy)phenyl]isoquinoline-1,5-diamine

7. 1,5-isoquinolinediamine, 6-methyl-n5-(3-(9h-purin-6-yl)-2-pyridinyl)-n1-(3-(trifluoromethoxy)phenyl)-

8. 1,5-isoquinolinediamine, 6-methyl-n5-[3-(9h-purin-6-yl)-2-pyridinyl]-n1-[3-(trifluoromethoxy)phenyl]-

9. Unii-t4e4i523ry

10. Schembl22356326

11. Gtpl11568

12. Ex-a2985

13. Zqd81946

14. Mfcd32062738

15. Zb1544

16. Ac-35618

17. Hy-111940

18. Cs-0094163

19. D81245

20. N5-(3-(9h-purin-6-yl)pyridin-2-yl)-6-methyl-n1-(3-(trifluoromethoxy)phenyl)isoquinoline-1,5-diamine

2.4 Create Date
2019-05-15
3 Chemical and Physical Properties
Molecular Weight 528.5 g/mol
Molecular Formula C27H19F3N8O
XLogP36.2
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count11
Rotatable Bond Count6
Exact Mass528.16339175 g/mol
Monoisotopic Mass528.16339175 g/mol
Topological Polar Surface Area114 Ų
Heavy Atom Count39
Formal Charge0
Complexity808
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Protein Kinase Inhibitors

Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)


Post Enquiry
POST ENQUIRY